Skip to content

Clinical trials

Phase 2 Primary Myelofibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Phase: Phase 2 Clear all

208 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20027
20031
20048
200510
200614
20079
20085
20093
20107
201110
20127
20138
20146
201512
20164
201712
20188
20195
20206
202118
20224
20236
20247
20254
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed114
Terminated37
Recruiting21
Active, not recruiting17
Withdrawn8
Unknown status6
Not yet recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center21
M.D. Anderson Cancer Center20
City of Hope Medical Center10
National Cancer Institute (NCI)9
Incyte Corporation7
John Mascarenhas7
Masonic Cancer Center, University of Minnesota6
H. Lee Moffitt Cancer Center and Research Institute5
Mayo Clinic5
Novartis Pharmaceuticals5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis208
Myeloproliferative Disorders81
Myelodysplastic Syndromes69
Leukemia, Myeloid, Acute65
Leukemia, Lymphocytic, Chronic, B-Cell64
Precursor Cell Lymphoblastic Leukemia-Lymphoma62
Polycythemia Vera58
Multiple Myeloma56
Hodgkin Disease51
Leukemia, Myelomonocytic, Chronic50

Trials

Showing 76 to 100 of 208. Each trial links to its page on Pharma Observatory.

108 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.